ES482084A1 - Un procedimiento para preparar un compuesto. - Google Patents

Un procedimiento para preparar un compuesto.

Info

Publication number
ES482084A1
ES482084A1 ES482084A ES482084A ES482084A1 ES 482084 A1 ES482084 A1 ES 482084A1 ES 482084 A ES482084 A ES 482084A ES 482084 A ES482084 A ES 482084A ES 482084 A1 ES482084 A1 ES 482084A1
Authority
ES
Spain
Prior art keywords
pyrrolo
quinolines
octahydro
preparation
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES482084A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/031,642 external-priority patent/US4235909A/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES482084A1 publication Critical patent/ES482084A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un procedimiento para la preparación de octahidro-2-H-pirrolo [3,4-g] quinolinas de fórmula general (I): **(fórmula)** en donde R(sup, 1) es H o alquilo C(sub, 1)-C(sub, 3); R(sup, 2) es alilo o alquilo C(sub, 1)- C(sub, 3); R(sup, 3) es H o CH(sub, 2)X, donde X es CN, CONH(sub, 2), SCH(sub, 3), SO(sub, 2)CH(sub, 3) u OCH(sub, 3); y sus sales de adición de ácido.
ES482084A 1979-01-22 1979-06-29 Un procedimiento para preparar un compuesto. Expired ES482084A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US506279A 1979-01-22 1979-01-22
US06/031,642 US4235909A (en) 1979-04-19 1979-04-19 Octahydro-2H-pyrrolo[3,4-g]quinolines

Publications (1)

Publication Number Publication Date
ES482084A1 true ES482084A1 (es) 1980-08-01

Family

ID=26673871

Family Applications (1)

Application Number Title Priority Date Filing Date
ES482084A Expired ES482084A1 (es) 1979-01-22 1979-06-29 Un procedimiento para preparar un compuesto.

Country Status (25)

Country Link
EP (1) EP0013788B1 (es)
JP (1) JPS55100385A (es)
AR (1) AR225012A1 (es)
AT (1) AT365189B (es)
AU (1) AU528035B2 (es)
BE (1) BE877328A (es)
CA (1) CA1131227A (es)
CH (2) CH641801A5 (es)
DD (1) DD144668A5 (es)
DE (1) DE2965277D1 (es)
DK (1) DK268979A (es)
ES (1) ES482084A1 (es)
FI (1) FI65248C (es)
FR (2) FR2446833A1 (es)
GB (1) GB2040917B (es)
IE (1) IE48295B1 (es)
IL (1) IL57665A (es)
LU (1) LU81440A1 (es)
NZ (1) NZ190834A (es)
PH (2) PH15118A (es)
PL (1) PL125785B1 (es)
PT (1) PT69828A (es)
RO (1) RO77442A (es)
SU (1) SU1113006A3 (es)
ZA (1) ZA793244B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL65269A0 (en) * 1981-03-24 1982-05-31 Lilly Co Eli 6-substituted hexahydroindazolo or hexahydroisoindolo isoquinolines
EP0127708B1 (en) * 1983-06-03 1987-09-09 Eli Lilly And Company Trans-dl-1-alkyl-6-alkoxyoctahydroquinolines
IL73001A0 (en) * 1983-09-26 1984-12-31 Lilly Co Eli Improvements in and relating to 6-oxodecahydroquinolines
US4595754A (en) * 1985-03-04 1986-06-17 Eli Lilly And Company Process for preparing cis N-alkylperhydroquinolines
AR067027A1 (es) * 2007-06-19 2009-09-30 Astrazeneca Ab Derivados de 2, 3-dihidro-1h-pirrol[3, 4b]quinolin-1-ona, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la modulacion de la actividad del receptor gaba a.
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途

Also Published As

Publication number Publication date
IL57665A (en) 1982-11-30
SU1113006A3 (ru) 1984-09-07
PT69828A (en) 1979-07-01
FI65248C (fi) 1984-04-10
ZA793244B (en) 1981-02-25
CA1131227A (en) 1982-09-07
AT365189B (de) 1981-12-28
JPS6233233B2 (es) 1987-07-20
IL57665A0 (en) 1979-10-31
DK268979A (da) 1980-07-23
PL125785B1 (en) 1983-06-30
PL216721A1 (es) 1980-06-16
AU528035B2 (en) 1983-04-14
DE2965277D1 (en) 1983-06-01
AU4844479A (en) 1980-07-31
NZ190834A (en) 1984-07-06
JPS55100385A (en) 1980-07-31
CH643258A5 (fr) 1984-05-30
GB2040917B (en) 1983-01-06
IE48295B1 (en) 1984-11-28
GB2040917A (en) 1980-09-03
AR225012A1 (es) 1982-02-15
PH16181A (en) 1983-07-25
FI792047A (fi) 1980-07-23
FR2446835B1 (es) 1982-04-23
IE791210L (en) 1980-10-19
DD144668A5 (de) 1980-10-29
FR2446833B1 (es) 1982-03-05
BE877328A (fr) 1979-12-28
EP0013788A1 (en) 1980-08-06
RO77442A (ro) 1982-10-26
FI65248B (fi) 1983-12-30
FR2446835A1 (fr) 1980-08-14
LU81440A1 (fr) 1979-09-12
PH15118A (en) 1982-08-10
FR2446833A1 (fr) 1980-08-14
EP0013788B1 (en) 1983-04-27
ATA452579A (de) 1981-05-15
CH641801A5 (fr) 1984-03-15

Similar Documents

Publication Publication Date Title
IE791209L (en) OCTAHYDRO PYRAZOLO (3,4-g) quinolines
CA1259074C (es)
ZA77787B (en) New derivatives of 3-quinoline carboxylic acid,process for preparing them and pharmaceutical compositions
ZA806682B (en) Novel quinoline derivatives,pharmaceutical compositions compositions containing such compounds,and method for the preparation of these compounds
EP0279149A3 (en) Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same
IL50932A (en) Carbo(hetero)bicyclic ethanolamine derivatives,process for their preparation and pharmaceutical compositions containing them
ES452420A1 (es) Procedimiento para la obtencion de soluciones solidas de al-caloides del cornezuelo de centeno y sus derivados sinteti- cos.
ES482084A1 (es) Un procedimiento para preparar un compuesto.
ES8303398A1 (es) Un procedimiento para la preparacion de un derivado de 2-piridincarboxamida.
SE8400445D0 (sv) Novel pharmaceutical active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivatives, their production and use
DE3061438D1 (en) Quinoline compounds, process for their preparation, and pharmaceutical compositions
ES8304977A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
CS194774B2 (en) Process for preparing derivatives of 1,4-dihydropyridine suitable especially as antihypertensive and antianginar medicament
PT82515A (en) Process for the preparation of pharmaceutical compositions containing dopamine agonists
IL57533A (en) 17alpha-acetylene derivatives of androst-4-ene,process for preparing them and pharmaceutical compositions containing them
ZA787302B (en) New compositions with an olefinyl succinimides base derivatives of the tris(amino-5 thia-3 pentyl)amine,their preparation process and their use as additives for lubricants
HUT56363A (en) Process for producing 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions comprising such compounds
ES8502088A1 (es) Un procedimiento para preparar un compuesto de nitrato piridilalquilico
ES8105331A1 (es) Procedimiento para preparar un alcaloide 2-metil-8(r) o (s) ergotpeptido
ES449874A1 (es) Procedimiento para la obtencion de un agente para el trata- miento de la mistitis bovina.
ES474575A1 (es) Procedimiento de producir (omega-aminoalcoxi)bibencilos far-maceuticamente activos
DE2962303D1 (en) Derivatives of ergopeptide alkaloids, process for their preparation and pharmaceutical compositions containing them
IL61602A0 (en) New derivatives of 1-aminopropan-2-ol,process for preparing them and pharmaceutical compositions containing them
ES8203843A1 (es) Procedimiento para la obtencion de amidas de acido 1,4-dihi-dropiridin-4-carboxilico
ES8407021A1 (es) Un procedimiento para la preparacion de derivados de acido 5-oxo-2-pirrolidinpropanoico.